Total Payments
$2,220
2024 Payments
$196.77
Companies
29
Transactions
139
Medicare Patients
1,451
Medicare Billing
$98,144
Payment Breakdown by Category
Food & Beverage$2,220 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,220 | 139 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $615.08 | 31 | $0 (2024) |
| Novo Nordisk Inc | $188.01 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $115.54 | 7 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $115.05 | 7 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $112.33 | 9 | $0 (2020) |
| Allergan, Inc. | $110.91 | 9 | $0 (2020) |
| PFIZER INC. | $104.20 | 8 | $0 (2021) |
| Amarin Pharma Inc. | $97.66 | 5 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $88.46 | 7 | $0 (2021) |
| Lilly USA, LLC | $87.16 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $196.77 | 9 | ABBVIE INC. ($127.99) |
| 2023 | $429.22 | 23 | AbbVie Inc. ($335.02) |
| 2022 | $294.05 | 18 | ABBVIE INC. ($137.34) |
| 2021 | $365.51 | 24 | Takeda Pharmaceuticals U.S.A., Inc. ($50.81) |
| 2020 | $260.47 | 17 | Amarin Pharma Inc. ($62.76) |
| 2019 | $177.37 | 14 | Allergan Inc. ($49.14) |
| 2018 | $296.74 | 18 | Novo Nordisk Inc ($91.64) |
| 2017 | $200.10 | 16 | AstraZeneca Pharmaceuticals LP ($35.72) |
All Payment Transactions
139 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Inflammation | ||||||
| 08/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Obesity | ||||||
| 05/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Obesity | ||||||
| 01/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Hematology | ||||||
| 10/05/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: VACCINES | ||||||
| 08/17/2023 | Currax Pharmaceuticals LLC | CONTRAVE (Drug), NEXLETOL, NEXLIZET | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Obesity | ||||||
| 08/03/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 337 | 447 | $76,763 | $22,116 |
| 2022 | 8 | 307 | 426 | $65,474 | $17,295 |
| 2021 | 11 | 381 | 550 | $76,712 | $30,118 |
| 2020 | 12 | 426 | 571 | $73,574 | $28,615 |
Total Patients
1,451
Total Services
1,994
Medicare Billing
$98,144
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 137 | $24,660 | $5,305 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 111 | $14,985 | $4,347 | 29.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $6,825 | $3,380 | 49.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 25 | $4,550 | $2,295 | 50.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 32 | 32 | $3,520 | $2,158 | 61.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $4,236 | $1,358 | 32.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 19 | $2,413 | $1,142 | 47.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 35 | 35 | $1,330 | $915.20 | 68.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 50 | 50 | $13,750 | $872.10 | 6.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $494.00 | $343.20 | 69.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 145 | $25,582 | $5,887 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 102 | $13,290 | $3,815 | 28.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 31 | 32 | $3,520 | $2,187 | 62.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 25 | $4,550 | $1,976 | 43.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 56 | 56 | $15,400 | $1,543 | 10.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 41 | 42 | $1,596 | $1,133 | 71.0% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 12 | 12 | $1,080 | $427.68 | 39.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $456.00 | $325.51 | 71.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 183 | $31,659 | $9,040 | 28.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 60 | 60 | $11,280 | $7,599 | 67.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 17 | 37 | $6,734 | $2,966 | 44.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $6,354 | $2,771 | 43.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 55 | 78 | $9,282 | $2,592 | 27.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 39 | $4,953 | $2,120 | 42.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 25 | 25 | $2,730 | $1,627 | 59.6% |
About Dr. Brittany Sullivan, MD
Dr. Brittany Sullivan, MD is a Family Medicine healthcare provider based in Burlington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2013. The National Provider Identifier (NPI) number assigned to this provider is 1063859452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brittany Sullivan, MD has received a total of $2,220 in payments from pharmaceutical and medical device companies, with $196.77 received in 2024. These payments were reported across 139 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,220).
As a Medicare-enrolled provider, Sullivan has provided services to 1,451 Medicare beneficiaries, totaling 1,994 services with total Medicare billing of $98,144. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Burlington, KY
- Active Since 05/27/2013
- Last Updated 03/09/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1063859452
Products in Payments
- VRAYLAR (Drug) $471.77
- UBRELVY (Drug) $115.03
- Vascepa (Drug) $97.66
- QULIPTA (Drug) $81.52
- TRELEGY ELLIPTA (Drug) $78.03
- Ozempic (Drug) $68.84
- CHANTIX (Drug) $63.38
- SYMBICORT (Drug) $60.62
- Livalo (Drug) $59.45
- MYRBETRIQ (Drug) $56.03
- EMGALITY (Drug) $47.61
- JARDIANCE (Drug) $45.83
- XIFAXAN (Drug) $42.26
- FARXIGA (Drug) $39.98
- TRULICITY (Drug) $39.55
- Tresiba (Drug) $37.69
- SHINGRIX (Biological) $37.51
- VYVANSE (Drug) $35.94
- JANUVIA (Drug) $34.36
- SPIRIVA RESPIMAT (Drug) $33.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Burlington
Krichna Sowles, Md, MD
Family Medicine — Payments: $17,218
Family Medicine $17,218
Dr. Jasmine Bajaj, Md, MD
Family Medicine — Payments: $8,590
Family Medicine $8,590
Dr. Richard Gilbert, Md, MD
Family Medicine — Payments: $7,905
Family Medicine $7,905
Michol Negron, D.o, D.O
Family Medicine — Payments: $7,588
Family Medicine $7,588
Dr. Donald Fisher, Md, MD
Family Medicine — Payments: $7,370
Family Medicine $7,370
Christopher Jarvis, M.d, M.D
Family Medicine — Payments: $5,691
Family Medicine $5,691